APRE
Aprea Therapeutics Inc
NASDAQ: APRE · HEALTHCARE · BIOTECHNOLOGY
$0.82
-2.14% today
Updated 2026-04-29
Market cap
$9.81M
P/E ratio
—
P/S ratio
34.34x
EPS (TTM)
$-1.93
Dividend yield
—
52W range
$1 – $2
Volume
0.5M
Aprea Therapeutics Inc (APRE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2007 | 2012 | 2013 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.90M | — | — | $-14.00M | $-15.25M | $-26.71M | $-41.80M | $-37.69M | $-25.01M | $-12.18M | $-13.56M | $-12.89M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $3702.00 | $3702.00 | $30901.00 | $25709.00 | $0.00 | $0.00 | $93093.00 | $15478.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $395440.00 | $329184.00 | $1.35M | $4.98M | $7.81M | $16.98M | $444459.00 | $489436.00 | $478141.00 |
| Free cash flow | $-1.90M | — | — | $-14.01M | $-15.25M | $-26.74M | $-41.83M | $-37.69M | $-25.01M | $-12.27M | $-13.57M | $-12.89M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $0.00 | $0.00 | — | — | — | — | — | — | — |